September 20, 2026

Muslim

A Trojan Horse for Cancer: Mount Sinai Scientists Unveil Groundbreaking Immunotherapy Targeting Tumor’s Protectors a-trojan-horse-for-cancer-mount-sinai-scientists-unveil-groundbreaking-immunotherapy-targeting-tumors-protectors

A Trojan Horse for Cancer: Mount Sinai Scientists Unveil Groundbreaking Immunotherapy Targeting Tumor’s Protectors

Muslim September 2, 2026
NEW YORK, NY – January 22, 2024 – In a significant scientific advancement poised to redefine the...
Read More Read more about A Trojan Horse for Cancer: Mount Sinai Scientists Unveil Groundbreaking Immunotherapy Targeting Tumor’s Protectors
Strengthening Global Health: India Commits US$ 85 Million to Advance WHO’s Traditional Medicine Agenda Agreement of Support by the Government of the Republic of India for the WHO Global Traditional Medicine Centre, 31 July 2024

Strengthening Global Health: India Commits US$ 85 Million to Advance WHO’s Traditional Medicine Agenda

Muslim September 2, 2026
In a landmark development for global public health, the Government of India has formally committed US$ 85...
Read More Read more about Strengthening Global Health: India Commits US$ 85 Million to Advance WHO’s Traditional Medicine Agenda
Pioneering the Future of Genomic Science: A Masterclass in Career Longevity with Alison Taylor-Beadling pioneering-the-future-of-genomic-science-a-masterclass-in-career-longevity-with-alison-taylor-beadling

Pioneering the Future of Genomic Science: A Masterclass in Career Longevity with Alison Taylor-Beadling

Muslim September 2, 2026
In the rapidly evolving landscape of modern medicine, few fields offer as much transformative potential as genomics....
Read More Read more about Pioneering the Future of Genomic Science: A Masterclass in Career Longevity with Alison Taylor-Beadling
Verrica Pharmaceuticals Completes Enrollment in Pivotal COVE-2 Trial for Ycanth in Common Warts, Anticipating Key Data in Early 2027 verrica-pharmaceuticals-completes-enrollment-in-pivotal-cove-2-trial-for-ycanth-in-common-warts-anticipating-key-data-in-early-2027

Verrica Pharmaceuticals Completes Enrollment in Pivotal COVE-2 Trial for Ycanth in Common Warts, Anticipating Key Data in Early 2027

Muslim August 28, 2026
A significant milestone has been reached in the development of Ycanth (VP-102) as Verrica Pharmaceuticals announced the...
Read More Read more about Verrica Pharmaceuticals Completes Enrollment in Pivotal COVE-2 Trial for Ycanth in Common Warts, Anticipating Key Data in Early 2027

You may have missed

the-great-insurance-debate-dissecting-the-role-of-health-insurers-in-americas-fiscal-crisis

The Great Insurance Debate: Dissecting the Role of Health Insurers in America’s Fiscal Crisis

Muslim September 20, 2026
beyond-the-cream-how-a-fathers-quest-for-relief-sparked-a-skincare-revolution-2

Beyond the Cream: How a Father’s Quest for Relief Sparked a Skincare Revolution

Lina Hope September 20, 2026
salk-scientists-unveil-estrogen-related-receptors-as-key-to-unlocking-energy-metabolism-and-combating-muscle-fatigue

Salk Scientists Unveil Estrogen-Related Receptors as Key to Unlocking Energy Metabolism and Combating Muscle Fatigue

Ammar Sabilarrohman September 20, 2026
the-architecture-of-hope-mapping-the-centuries-long-evolution-of-breast-cancer-treatment

The Architecture of Hope: Mapping the Centuries-Long Evolution of Breast Cancer Treatment

Suro Senen September 20, 2026